The global Cognitive Decline Market is stipulated to witness a CAGR of 5.8% by the year 2022-2032. Digital innovation is the buzzword. As such, digital health unicorns are coming up. Digital up swinging is thus expected to take the entire healthcare vertical by storm in the next 10 years. This would be the state of the healthcare vertical shortly.
Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to exhibit a CAGR of 5.8 % over the forecast period (2021-2031).
Cognitive decline is a condition in which the brain does not work as well as it should. According to the Centers of Disease Control and Prevention (CDC) report, the prevalence of cognitive decline in the U.S. is 11.1%. This rising prevalence of cognitive decline is one of the major factors driving the growth of the market.
Want insights into the cognitive decline market? Ask for Sample!@ https://www.persistencemarketresearch.com/samples/32968
Non-invasive brain stimulation (NIBS) is gaining traction as a clinically effective tool for identifying and treating a wide range of mental illnesses. Widespread use of NIBS will be contingent on its efficacy as demonstrated in sham-controlled multi-center trials, but current indications point to it having a significant impact on the treatment of disorders seen in a variety of specialties, including neurology, psychiatry, pediatrics, physical therapy, and physical medicine and rehabilitation.
Because non-invasive brain stimulation carries minimal risk, it is associated with fewer side effects and consequences. This will be one of the primary driving forces in the market over the projected period of 2022-2032.
Companies are focusing on developing innovative and competitive products to meet unmet market needs. There are multiple licensing and collaboration agreements for the development and commercialization of products in the areas of cognitive decline. New market entrants are working on an effective pricing strategy.
Business units are restructuring initiatives to enhance business effectiveness. Diversification of companies’ efforts is also leading to the development of other generic drugs.
Would like to know what the cognitive decline market has in store? Look through the “ToC” of the cognitive decline market report!@ https://www.persistencemarketresearch.com/market-research/cognitive-decline-market/toc
Companies are entering into strategic alliances with other pharmaceutical companies and government bodies for faster development of present pipeline drugs.
Key Takeaways from Market Study
- By product type, drug therapy held 53% market value share in 2020.
- By indication, mild cognitive impairment (MCI) held 78% market value share in 2020.
- Hospitals dominated the cognitive decline market with a share of 39.1% in 2020, owing to more effective treatment within these facilities.
- By region, North America dominated the global cognitive decline market with a value share of around 36.8% in 2020.
“Positive reimbursement paradigm for cognitive decline and innovative products & solutions for treatment will promote market growth,” says an analyst of Persistence Market Research.
Key players are focusing on forming strategic partnerships through acquisitions and mergers to enhance their presence across the world, resulting in increased customer base.
In March 2021, Deutsches Zentrum für Neurodegenerative Erkrankungen and Eisai Co., Ltd. entered into a research agreement to create novel treatments for neurodegenerative disorders, including Alzheimer’s disease (AD).
In August 2019, electroCore, Inc. announced a research collaboration with the Massachusetts General Hospital to explore non-invasive Vagus nerve stimulation in neuroinflammation.
Keeping a tab on Key players in the cognitive decline market? Go to “Purchase Now” to decipher the competitive analysis in our cognitive decline market report@ https://www.persistencemarketresearch.com/checkout/32968
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the cognitive decline market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
Best Research Reports for you-
Hearing Aids Market –
The global hearing aids market was valued at US$ 7.4 Bn in 2020, and is expected to register a CAGR of 5.2% and reach a valuation of US$ 12.9 Bn by the end of 2031.
MRI Systems Market –
The global MRI systems market was valued at US$ 8 Bn in 2020, and is expected to register a CAGR of 6.5% over the forecast period (2021-2031).
Examination and Surgical Gloves Market –
Revenue from the sales of examination and surgical gloves amount are expected to attain a valuation of US$ 13.9 Bn by the end of 2031.
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact us: Persistence Market Research Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 Sales – email@example.com
Menafn, Reportedtimes, Financial Content, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English